Cryoablation Devices Market Growth Accelerated By Advancing Technology

Cryoablation devices are medical devices used to freeze and destroy diseased tissue. Cryoablation devices offer several advantages over traditional surgical procedures including minimal bleeding, scarring or damage to surrounding tissues, reduced pain, shorter hospital stays, and faster recovery times.

The global Cryoablation Devices Market is estimated to be valued at US$ 3628.03 Bn in 2023 and is expected to exhibit a CAGR of 13% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
Advancing technology in cryoablation devices is one of the major trends driving market growth. Manufacturers are increasingly focusing on developing innovative cryoablation devices with advanced features like improved imaging technology, precision in treatment, larger treatment areas and minimal side effects. Miniaturization of devices has further improved treatment outcomes. Ongoing research in cryogenics and nanotechnology is also expected to lead to development of next-generation cryoablation devices with superior capabilities. This is expanding the potential applications of cryoablation in treating various types of cancers and cardiac arrhythmias, thereby fueling adoption of cryoablation devices.

Segment Analysis
The global cryoablation devices market is dominated by the cryoablation systems segment. Cryoablation systems are widely used for minimally-invasive procedures to destroy diseased tissues or tumors through freezing. Cryoablation systems allow precise placement of cryoprobes or cryogenic needles into target tissues under imaging guidance. This controlled freezing causes necrosis or death of tissues without affecting surrounding healthy tissues. The rising preference for minimally-invasive surgeries and increasing adoption of cryoablation for treatment of cancer and cardiac arrhythmias have driven the demand for cryoablation systems.

Key Takeaways
The Global Cryoablation Devices Market Size is expected to witness high growth during the forecast period of 2024 to 2031.

Regional analysis
North America is currently the dominant region in the cryoablation devices market. The high adoption of minimally-invasive procedures, growing prevalence of cancer and cardiac arrhythmias, and presence of key market players have fueled market growth in North America. Additionally, favorable reimbursement policies and guidelines for cryoablation procedures in countries like the US and Canada have boosted the regional market. Asia Pacific is expected to grow at the fastest pace during the forecast period due to rising healthcare expenditure, increasing medical tourism, and growing awareness about cryoablation technologies in emerging countries.

Key players
Key players operating in the cryoablation devices market are Agilent Technologies, Inc., Biomax Informatics AG, DNAnexus, Inc., Genedata AG, Intrexon Bioinformatics Germany GmbH, Illumina Inc., Perkinelmer Inc., Qiagen N.V., Seven Bridges Genomics Inc., and Thermo Fisher Scientific, Inc. Agilent Technologies offers a range of cryoablation equipment including cryoprobes, generators, and equipment for imaging guidance. Biomax Informatics provides cloud-based bioinformatics solutions and services for processing and analyzing omics data to support discovery and development of cryoablation therapies.

 

Get more insights on this topic:
https://www.dailyprbulletin.com/cryoablation-devices-market-analysis/

Check below trending articles on this topic:
https://www.rapidwebwire.com/office-furniture-market-regional/

Comments

Post a Comment

Popular posts from this blog

Hypoglycemic Drugs Market is Estimated to Witness High Growth Owing to Increasing Prevalence of Diabetes in the Geriatric Population

Image
Hypoglycemic drugs or anti-diabetic drugs are medications used to treat diabetes mellitus by lowering blood glucose levels. Some key hypoglycemic drugs include insulin, sulfonylureas, metformin, thiazolidinediones, DPP-4 inhibitors, SGLT2 inhibitors and GLP-1 receptor agonists. These drugs help control blood sugar levels in diabetics and prevent or delay diabetes-related health complications. The global hypoglycemic drugs market is estimated to be valued at US$ 720.72 Mn in 2023 and is expected to exhibit a CAGR of 4.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: The growth of the global hypoglycemic drugs market is majorly driven by the increasing prevalence of diabetes in the geriatric population globally. As per estimates, around 1 in every 11 people aged 65 years and above have diabetes. Further, the number of people with diabetes in this age group is anticipated to grow from 25.9 million in 2017 to...
Read more

Clinical Trials Rising with Digital Technologies Adoption

Image
 Clinical trials support services play a vital role in assisting sponsors and life science companies to conduct clinical trials in a precise and well-organized manner.These services assist pharmaceutical companies in patient recruitment, data management, site management, and overall clinical trial management. With rising complexities in clinical trials owing to integration of technologies like telehealth and remote patient monitoring, the demand for these support services is growing substantially. The global Clinical Trials Support Services Market is estimated to be valued at US$ 22.38 Bn in 2023 and is expected to exhibit a CAGR of 7.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: The growing adoption of digital technologies across clinical trials is a key trend accelerating the growth of the clinical trials support services market. Digital tools like electronic data capture, clinical trial manag...
Read more

Vegan Yogurt Market is Poised for Growth Driven by Rising Health Consciousness

Image
Vegan yogurt is a dairy-free alternative to conventional yogurt made from plant-based milk such as soy, almond, oat, coconut or rice. It provides similar texture and taste to dairy yogurt but without any animal products.Vegan yogurt offers several health advantages over dairy yogurt as it is devoid of lactose, cholesterol and saturated fats. The growing number of people adopting vegan and flexitarian diets has driven the demand for plant-based dairy alternatives like vegan yogurt. The global vegan yogurt market is estimated to be valued at US$ 4.15 Mn in 2024 and is expected to exhibit a CAGR of 4.2% over the forecast period 2024 to 2031. Key Takeaways Key players- Met Fods, Cocos Organic, Hain Celestial, EasiYo Product Limited, Danone, General Mills Inc., Stonyfield Far, Inc., Daiya Foods Inc.m Good Karma foods, Inc.m Hudson River Foodsm NANCY'S, Kite Hill, COYO Pty lTd., Nush Foods, Chobani, LLC, Barambah Oraganics Pty Ltd., Blue Diamond Growers, Dean Foodsm General Mills Inc...
Read more